White House: Nine U.S. Drugmakers Agree to Lower Prices
December 23, 2025The White House
announced on Friday that nine drugmakers - Amgen, Bristol Myers Sq...
December 23, 2025The White House
announced on Friday that nine drugmakers - Amgen, Bristol Myers Squibb,
Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and
Sanofi - have agreed to lower the costs of their prescription drugs in the
U.S., compared to what they are in other ...